000 01663 a2200457 4500
005 20250517174859.0
264 0 _c20171212
008 201712s 0 0 eng d
022 _a1938-3673
024 7 _a10.1189/jlb.3A0717-311R
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKiripolsky, Jeremy
245 0 0 _aMyd88 is required for disease development in a primary Sjögren's syndrome mouse model.
_h[electronic resource]
260 _bJournal of leukocyte biology
_c12 2017
300 _a1411-1420 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAntibodies, Antinuclear
_ximmunology
650 0 4 _aAutoantibodies
_ximmunology
650 0 4 _aB-Lymphocytes
_xdrug effects
650 0 4 _aCross-Linking Reagents
_xmetabolism
650 0 4 _aDisease Models, Animal
650 0 4 _aDisease Progression
650 0 4 _aInflammation
_xpathology
650 0 4 _aKidney
_xdrug effects
650 0 4 _aLacrimal Apparatus
_xdrug effects
650 0 4 _aLipopolysaccharides
_xpharmacology
650 0 4 _aLung
_xdrug effects
650 0 4 _aMice, Inbred NOD
650 0 4 _aMyeloid Differentiation Factor 88
_xmetabolism
650 0 4 _aReceptors, Antigen, B-Cell
_xmetabolism
650 0 4 _aSalivary Glands
_xdrug effects
650 0 4 _aSalivation
_xdrug effects
650 0 4 _aSjogren's Syndrome
_ximmunology
650 0 4 _aT-Lymphocytes
_xdrug effects
700 1 _aMcCabe, Liam G
700 1 _aGaile, Daniel P
700 1 _aKramer, Jill M
773 0 _tJournal of leukocyte biology
_gvol. 102
_gno. 6
_gp. 1411-1420
856 4 0 _uhttps://doi.org/10.1189/jlb.3A0717-311R
_zAvailable from publisher's website
999 _c27605527
_d27605527